Clinical trials
Cardiogenic Shock clinical trials
Below are recruiting cardiogenic shock clinical trials, each written for real people, not researchers. We’re tracking 86 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05185492Recruiting
Registry for treatment outcomes in cardiogenic shock
This trial is a registry that collects information about people with cardiogenic shock to better understand outcomes and improve management. It may help by contributing real-world data on what treatments and timing work best for different heart-related shock causes.
Weston, FloridaAges 18 years+ - NCT03378739Recruiting
Registry study for cardiogenic shock care at Inova
This study collects information about how cardiogenic shock is treated in the hospital at Inova (for sudden worsening heart failure or a heart attack). It may help improve care for future patients, because the research team will learn what treatments and outcomes are associated with different situations.
Falls Church, VirginiaAges 18–85 - NCT06862700Recruiting
Less vasopressors for heart shock on ECMO
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06964685Recruiting
Impella heart pump in heart attack with shock
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
Jonesboro, ArkansasAges 18 years+ - NCT06475456Recruiting
Italian Pilot Study of Cardiogenic Shock Treatment
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
ChivassoAges 18–75 - NCT06572826Recruiting
Cardiac rehab after cardiogenic shock recovery
This study looks at whether a cardiac rehab program (exercise and education) can help people recover after being treated for cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood.
MilanAges 18–110 - NCT05485376Recruiting
Pulmonary artery catheter use in cardiogenic shock patients
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
Boston, MassachusettsAges 18–90 - NCT04419480Recruiting
Monitoring to help prevent complications after cardiogenic shock
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
Falls Church, VirginiaAges 18 years+ - NCT06638268Recruiting
TAVI for severe aortic stenosis in cardiogenic shock
This study tests whether a procedure called TAVI (a valve replacement done through a tube in the leg) can help people with severe aortic stenosis who are in cardiogenic shock, a dangerous condition where the heart can't pump enough blood. The goal is to see if urgent valve replacement improves survival.
Copenhagen OAges Any age - NCT07619144Recruiting
Improving Heart Pump Outcomes Using Advanced Data Analysis
This study examines detailed data from patients who received an Impella 5.5 heart pump to treat cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood. Researchers use advanced computer analysis to understand what helps patients recover best.
ViennaAges 18 years+ - NCT04184635Recruiting
ECMO for heart-attack shock in the ICU
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
ParisAges 18 years+ - NCT04682483Recruiting
Cardiogenic shock registry to improve care and outcomes
This registry collects information about people who have cardiogenic shock, a serious condition where the heart cannot pump enough blood. Your participation may help doctors learn which treatments and monitoring best improve outcomes.
Weston, FloridaAges 18 years+ - NCT05700617RecruitingEarly Phase 1
Testing cardiac pumping strength in cardiogenic shock
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
Chicago, IllinoisAges 18 years+ - NCT07643610Recruiting
Heart Failure Crisis Registry Study
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Basel, Canton of Basel-CityAges 18 years+ - NCT05752383Recruiting
Study of how cardiogenic shock patients do in the ICU
This study looks at what happens to people with cardiogenic shock while they are in the intensive care unit (ICU), including how their heart and blood circulation change over time. It may help doctors better understand the course of illness in this specific type of shock and improve care.
AmiensAges 18 years+ - NCT05168462RecruitingPhase 4
Lower blood pressure goal in heart-attack shock patients
This study compares two blood pressure targets in people with cardiogenic shock after a heart attack. It looks at whether the lower target can improve outcomes and help evaluate treatment costs.
AmsterdamAges 18 years+ - NCT06369818Recruiting
Heart output measurement in shock patients on life support
This study tests if a new way of measuring heart function (using sound waves and breath analysis) works well in patients who are in severe heart failure and need a heart-lung machine. It might help doctors better monitor patients after heart surgery.
MünsterAges 18 years+ - NCT07655479Recruiting
Switching to a stronger heart pump after heart attack
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
Düsseldorf, North Rhine-WestphaliaAges 18–77 - NCT06955936Recruiting
Blood filtering for shock after heart attack
This trial tests a new blood-filtering device called Efferon CT for people with cardiogenic shock after a heart attack. The device aims to help your body recover by cleaning harmful substances from your blood, and you might join if you are diagnosed early and don't have other serious health issues.
TomskAges 18–80 - NCT05527717RecruitingPhase 4
PCI vs strategy for heart attack shock needing ECMO
This study looks at the best way to reopen blocked heart arteries (using a stent procedure) in people who had a heart attack complicated by severe shock and need a life-support machine called VA-ECMO. It may help improve outcomes by testing which revascularization approach works best for multi-vessel blockages.
SeoulAges 19 years+ - NCT06696235RecruitingPhase 4
Comparing fast vs standard kidney therapy for heart shock patients on ECMO
This trial tests whether starting kidney replacement therapy faster or at the usual time improves outcomes for people with severe heart failure (cardiogenic shock) who are on a heart-lung machine (ECMO) and develop sudden kidney injury.
SeoulAges 19 years+ - NCT06535503Recruiting
Heart attack with shock: Study of patient outcomes in Abu Dhabi
This study looks at the medical records of people who had a severe heart attack (STEMI) that caused cardiogenic shock. Researchers want to understand how these patients did during their hospital stay to improve care in the future.
Abu Dhabi, Abu Dhabi EmirateAges 18 years+ - NCT07141355Recruiting
Empagliflozin's effect on small blood vessels in cardiogenic shock
This study looks at whether empagliflozin, a diabetes medicine, helps improve blood flow in tiny blood vessels for people in cardiogenic shock. If it helps, it could improve recovery for people with this serious heart condition.
StrasbourgAges 18 years+ - NCT06965504Recruiting
Heart failure medications with an Impella heart pump for cardiogenic shock
This study tests whether a special heart pump (Impella 5.5) can help patients with severe heart failure (cardiogenic shock) safely start and increase their heart failure medications. The goal is to see if this approach can help the heart recover and improve outcomes.
Tampa, FloridaAges 18–80
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiogenic shock?
- Yes. Clin2 currently lists 86 recruiting cardiogenic shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiogenic shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiogenic shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.